← Archive
IN FORCE SEZ / EOU / FTWZ

Agenda of Approval Committee meeting to be held on 09.06.2026 -JNPA SEZ.

Reliability

In force — no superseding record on file.

Document text

aica fasts anfite aa SEEPZ SPECIAL ECONOMIC ZONE

wet (Ga), Aas ANDHERI (EAST), MUMBAI

aad& fre AGENDA FOR

EG KsI 8 We aT JNPA) & aedl Ager : Sarath faery _airftte ata (Special Economic Zone) # fag ats wanes Baia Ht don!

}

MEETING OF THE APPROVAL COMMITTEE FOR SECTOR SPECIFIC SPECIAL ECONOMIC ZONE MULTI SECTOR OF M/s. Jawaharlal Nehru Port Authority (JNPA). ;

VENUE : Conference Hall, 2®¢ Floor, The Office of the Development Commissioner, SEEPZ-SEZ, Andheri (East), Mumbai. fesi@ : TATA, 09 June 2026 DATE : Tuesday, 09 June 2026 aaa 12:00 HURTS (GITEX12:00 Fh TIME : 12:00 PM

Hifetaat =: 71dh dow Meeting :71st No

.

| | | | i

| | | | | | || | | | |

| AVE Taster ASK We seaiitet (INPA-SEZ) & AedWaex&q Aret-fafase faery | anf ata (Sector Specific Special Economic Zone for Multisector) ® Watr | 4 fase arqra, dives-cagats (SEEPZ-SEZ) @ Htaara A Aaa, 09 set | | 2026 HF aralfstd stealaet aiatfa ft toa

Meeting of the Approval Committee for Sector Specific Special Economic Zone for Multisector of M/s. Jawaharlal Nehru Port Authority JNPA-SEZ under the Chairmanship of Development Commissioner, SEEPZ-SEZ on Tuesday, 09th June 2026.

qaath INDEX

|||Agenda Item No.|Agenda Item No.|Subject||
|---|---|---|---|---|---|
||||areal|ae ware 01:-|27.04.2026 YTaratedfon&Higa Ft||
||<br>|<br>|<br>i|;|AgendaItem No.<br>RTA <br>AgendaItem|Item No.01: -<br> HeHAH02:-<br>Item No. 02: -|ise!<br>a<br>Confirmations of the<br>minutes<br>of the<br>meeting tobeheldon27.04.2026<br>auatiel cart fanfta suerdidr-cwasas,<br>RUT, AgY AAS - 400702H Vrer-6, cate<br>0|:<br>i|
||||||HEM 603 W<br>eet 8,500 at Alexey sawyer||
||||||wareyencs Wede fakes & veda &||
||||||atera||
||<br>|<br>|||||The<br>proposal<br>of<br>M/s.<br>SRS<br>Pharmaceuticals<br>Private<br>Limited<br>for<br>carryingoutManufacturing activities of<br>various Pharma Items and Research &||
||||||Development<br>Services,<br>as<br>detailed<br>in||
|||<br>|||||Annexure “A”, over an areaadmeasuring<br>8,500 Sq. Mtrs. at PlotNo. 603, Sector-<br>6, JNPT SEZ, developed byJNPT, Uran,|q|
||<br>|<br>|||wre<br>AgendaItem No.|Ae HaATH 03:-<br>Item No.03:-|NaviMumbai—400702.<br>vavad-wndseysts,<br>= suerte,<br>aT,ara Aas a feet faeuarea wasas<br>sare 4, fear fre Genta<br>ywelcor &,||
|**|**||||4,370.05 at we afaea ate sist &||
||||||.|
||<br>.||||||

|

fares<br>B wea Hace
Application received from M/s. SRV
Global Freight Pvt. Ltd. for addition of
area admeasuring4,370.05 Sq. ft. to the
already<br>existing SEZ Unit located<br>at
NSBP-FTWZ, JNPA, Uran, Navi Mumbai
withoutrevisioninprojections.

HRI ERR EERE RARER ERE

.

OO

on of| |area admeasuring4,370.05 Sq. ft. to the| |already<br>existing SEZ Unit located<br>at| |NSBP-FTWZ, JNPA, Uran, Navi Mumbai| |withoutrevisioninprojections.|

HRI ERR EERE RARER ERE

.

OO

foare sae, Uicar-tar Fr Heater at 28.04.2026 a fedra aa vicar aa da, dow as, Aad Ff ae aeadie-as, agqa-se, adt yeas-400707 & aa fare anes aa & fore Heasiaer alae hr 70dl doa ar araige|

Minutes of 70" Meeting of the Approval Committee for Multi Sector Specific Special Economic Zone of M/s. JNPA-SEZ, Taluka-Uran, Navi Mumbai-400707 under the Chairmanship of Development Commissioner, SEEPZ-SEZ held on 28.04.2026, at Second Floor SEEPZ Service Centre, SEEPZ SEZ, Mumbai. Name of the SEZ _ | - M/s. Jawaharlal Nehru Port Authority. a | Sector | Multi Product SEZ Meeting No. 70 th | ACT age 70at | | feces 28.04.2026 Date 28.04.2026

|Sued BWae/_ Members Present:|Sued BWae/_ Members Present:|-|.|||
|---|---|---|---|---|---|
||Paes Hr caret|Uaa aa||Waroeat||
||’ Name ofMembers|Designation||Organization||
|1|St. ARQ HR, AavHT|Taw Peres sy,||Sicst-Bt||
||Shri. Mayur R. Mankar|Jt. Development||SEEPZ-SEZ||
|||Commissioner||||
|2|at. Geter sear|GaP 3<br>wee|Ha HH Halas, Aas & aad|||
||Shri. Sunil Aghawane|Joint Commissioner, Income}|Nominee ofCommissioner of Income|||
|||Tax||Tax office, Mumbai||
|3|ay afarquay|3u faders sete)|sfatter setewd,ass & afar|||
||Shri.

s, Aas & aad|||
||Shri. Sunil Aghawane|Joint Commissioner, Income}|Nominee ofCommissioner of Income|||
|||Tax||Tax office, Mumbai||
|3|ay afarquay|3u faders sete)|sfatter setewd,ass & afar|||
||Shri. Backiyavelu Mutharasu||Deputy DirectorDGFT|Nominee ofthe Additional! DGFT,|||
|||||Mumbai||
|4|afttdi beth|ean<br>Har yew sry | Hear Yow sry, seta, WR aif,||||
||Shri Ravindra Keny|AssistantCommissionerof<br>Customs|Bet a arta /<br>Nominee ofCommissionerofCustoms,|||
|||-||General, Air Cargo, Sahar|:|
|5|at Utara altel|Sarr fatter|Sef|sedis, AaWTE wat & arfadt||
||Shri Dhananjay Koli|Industry Inspector||Nominee ofDC Industries,||
|||||GovernmentofMaharashtra||

| AY Ha Hat we fafafee arith Suate-waSaS | Shri. Jay Manoj Shah Specified Officer JNPA-SEZ , | 7 | stadt Raa arferarz fafatée sftert eat Smt. Smitha Nambiar Specified Officer MINDSPACE-SEZ at gefter wet, afaat (el Ast), at genre we, Shri Hanish Rathi, ADC (New SEZ), Shri Palash | Bras (Hcs-Bst), at aad, afast (= Ast), A Shankar, ADC (SEEPZ SEZ), Shri Jai deep, ADC Gavlet fe, afast (=y Ast), at Weer Raver, (NEW SEZ), Shri Soodershan Shindde, ADC (New | afast (= Ast), A stat Hay wal, BAHT (FL sez), Shri Rahul Shivannagol, ADC (NEW SEZ), Shri pLoT IIS Bat). aR gait Fecaneht aTIerer (STAT ) a dow. at > Aman Kumar: Sharma, ADC- (NEW: SEZ) -and°-Ms:- = = =~ | Vere atk Sah Yaw Harerst & fore sufeyT TI Divyanshi Goyal (LDC) also attended for assistance | and smooth functioning of the meeting. | WIS Fe U, 01; fie 24.03.2026 #1 sraifia 694i =Agenda Item No.

| Vere atk Sah Yaw Harerst & fore sufeyT TI Divyanshi Goyal (LDC) also attended for assistance | and smooth functioning of the meeting. | WIS Fe U, 01; fie 24.03.2026 #1 sraifia 694i =Agenda Item No. 01: Confirmation of Minutes of deere ORR Sr oeT ~[the][69th][Meeting] held on 24.03.2026. a 24.03.2026 mY Helista codt dom & alga The Minutes of the 69th Meeting held on | ht adearafa & gfe Hr a1 24.03.2026 were confirmed with consensus. WislHe W. 02: Fat: alearsareg def ustaaa fees Agenda Item No. 02: Proposal of M/s. Onnsynex aor atfafers aa ae as wore earfta wey Ventures Private Limited for setting up of a new waelt wear | unit for warehousing and storage & Logistics of | Items at JNPA SEZ. | tet oimastrs dai migde fees A cig M/s. Onnsynex Ventures Private Limited has was a 4 wedi wadteeyps We-SaeX % applied for setting up a FTWZ Unit for Warehousing SeneTse Fax 3 7 1000 3 a a et H SaRETSRAT Ut and storage & Logistics of Items at JNPA SEZ isl el aay Fie an hy i clsSORES area admeasuring to 1000 sq. ft. at warehouse no. aut &t saat %200ara watt & shah 3 in NSBP FTWZ Co-developer envisaging FOB . ay ced ean aor BOSH wen oe or18S whe a on value of Export Rs. 200/- in Lakh, FE Outgo of Rs. | caené wearin 2 erknot 3s ham 15.00/- in Lakh and NFE of Rs. 185.00/- in Lakh | arama) IT over a period of 5 years with employment | generation of 5 employees. |

|

.

|

| .

  • feof: xqated oat aA ue ale feo fe fae a Decision: Approval Committee noted that the unit cn fer ae a as. ae 0as notbmitsubmit t eded the detadeta il eed HSN Codeode for ththe

.

  • feof: xqated oat aA ue ale feo fe fae a Decision: Approval Committee noted that the unit cn fer ae a as. ae 0as notbmitsubmit t eded the detadeta il eed HSN Codeode for ththe

  • . fadePRESHSN wis Sar aét setfra aterBI STAT items to be warehoused or to be stored. After deliberation, the Committee approved

  • fraz-faast & aa, afafa a faeafafsa aaf a the proposal as per attached layout subject to athe amd — x aight & 2: following conditions: 2.1. GARCARAots weg PearMIN! be1. warehousedTo submit itemsor stored. wise HSN Code for the items to gars or Shitendt ae aftics wd vert Fareta@ «2. The unit shall adhere to and comply with all ah den er Sort restrictions, guidelines, and instructions vd Presi STRGr Ter G IA T THEFT, TT TSSai, fe sas at t Ministryissued fromof Comti me rceto time& Industry,by the asDGFTapplicableand theto

    1. ay ah ant + ah 3. The unit shall exercise due diligence and ensure Bary Wet a TASS compliance with all conditions prescribed under the sear, 2005 va Sad sivia say1 Fazal a SEZ Act, 2005 and the rules framed thereunder. ced Pata at oat pr oof ae Ursa 4. Committee directed Specified Officer, INPA SEZ to visit the premises and submit their report for the

  • OT SFT same.

    1. ama a Afee after, adic wes aT ORE cor Pao at cen Ss Baer F aot Rare Wega Be or Meer ar S| |

Specified Officer, INPA SEZ to visit the premises and submit their report for the

  • OT SFT same.

    1. ama a Afee after, adic wes aT ORE cor Pao at cen Ss Baer F aot Rare Wega Be or Meer ar S| |

wist_4¢_v_03: tee =e sar fasrtoh fat: e s Agenda Item |No. 03:; Proposal of, M/s. Nhava| ant wediy fer wrath - srs + att P WaettAbaeT WETsme| 41,67,145.95244 alex wea Sheva1,67,145.952BusinessSq ParkMtrs Ltd.in theifo r existingaddition Unitof areaLocatedof NSBP-FTWZ JNPA without revision in projections. orm Ta Nel Wigs arc, at waged The unit had submitted the application for addition wndissrpts A fit 8, F 1,67,145.952a7 Alex PP ad4 Peta weal (aster) F ferst deers a fear projections into already existing SEZ Unit located Ta 1 Se a, sHs 4 aM EAM ex sip styaet ¥ at NSBP-FTWZ The proposed change in items of as 5 asi dt safe & fey sis sfsa & area S fyafor manufacturing and revised projection’s in LOA as aegelt 4 aRacs or oft ware fear SI below:-

==> picture [597 x 547] intentionally omitted <==

of as 5 asi dt safe & fey sis sfsa & area S fyafor manufacturing and revised projection’s in LOA as aegelt 4 aRacs or oft ware fear SI below:-

==> picture [597 x 547] intentionally omitted <==

----- Start of picture text -----<br> es<br>Revised Area and Location: ,<br>| lExisting Location Proposed Proposed<br>| | & Admeasuring Location for Location Post |<br>| || Area Admeasuringaddition & Admeasuringaddition& ||<br>i NSBP Co- Plot 2, NSBP Co- | Plot 2, NSBP Co- |<br>| | Area Area<br>Developer, JNPA- |Developer, JNPA- | Developer, JNPA- |<br>SEZ SEZ SEZ<br>Admeasuring<br>Area—<br>|| ~-""- eae eee asFAdmeasuringAreaSq.— 44992.20Meter -|- SerA@measuring—-1,67,145.952. =- 7 Sqae| BAB(1,67,145.952~y uaABBASZ- eter—=g-: Sq + ~ fT|! ~ - wee wee oe ee ee ee . -- ~ eee ee [cee] [cee] -<br>pot Meter 4499220.<br>[The unit has provided that there is revision ioo<br>| in_employment projections due to proposed addition:<br>| Employment Projections for Next 5 Year<br>| ‘sr. No.| Particulars |15t Year| 24 3" 4th sth |<br>| Year | year | Year | Year |<br>| A {Skilled and<br>! | Semi |<br>| Skilled |<br>Indirect 4 12 20<br>| | Employees |<br>| | Employees<br>- | Total |<br>Employees<br>----- End of picture text -----<br>

,

| |

: :

ear |<br>| A {Skilled and<br>! | Semi |<br>| Skilled |<br>Indirect 4 12 20<br>| | Employees |<br>| | Employees<br>- | Total |<br>Employees<br>----- End of picture text -----<br>

,

| |

: :

fauia: ferrz-faaet 2 aa, ufetfa a Nhava Sheva Decision: After deliberation, the Committee Business Park Ltd. & 3a weara wm aap & a approved the proposal of Nhava Sheva Business - @ 1,67,145.952 at Alex ar aa alsa At aga ag Mtrs in their existing Unit Located NSBP-FIWZ ars off] JNPA. With condition that this open space should be not reserved for public utility / common place san 3rera, Gata a fafes atreaht a fade fea. fee a aratea at alfa fetter Rutt sich sa fects & aie ws gett aeae & utter a eet AY Further, the Committee directed the Specified que @ Ruré seh Wael Wedd wt | ae facta officer to provide the physical inspection report to aetaTAT A wer cut F Ae wees uRRaia wt ead the office regarding if any challenges faced by eu wp dafeun cage & aed aqui at ag | custom for examination of containers . This . permission has been sanctioned due to present war like situation in gulf countries . WislWedd We ¥.04:*eef yaariew stet fe eS ENT Agenda Item No. 04: Proposal of M/s. Aquatic afer wee, RRA Gacht Fleer cer ait amet F afafafaal & fac aegait Hl Gat & sis SeT H Remedies Limited for Approval W.r.t (Broad 4 Dlg Banding) of list of items for Trading activity in BaierSETS wearlestSET EET TT Ta SSH Hotes Fat SI ae ; a their existing Letter of Approval without revision in projections.

pproval W.r.t (Broad 4 Dlg Banding) of list of items for Trading activity in BaierSETS wearlestSET EET TT Ta SSH Hotes Fat SI ae ; a their existing Letter of Approval without revision in projections. gfe 4 sat Alger cex sith oyaet 4 efer afefafeal = The unit had submitted an application for Addition o fey agai dt yet 4 sfafedt aga cits Gis (Broad Banding) as mentioned in List of items for afSt) Sg WH aden Wega fear el trading activity in their existing Letter of Approval.

.

|‘Existing<br>Approveditems:<br>~|‘Existing<br>Approveditems:<br>~|‘Existing<br>Approveditems:<br>~|ee|ee|ee||
|---|---|---|---|---|---|---|
||||<br>ITC HS Code /||<br>||||||
|_<br>Sr.no<br>Item Description<br>|<br>cPC<br>°<br>|;<br>|<br>rl 29362700<br>Ascorbic Acid (Vitamin C)<br>|<br>| 2 |<br>29393000<br>Caffeine Anhydrous<br>| 3 |<br>29411030<br>Amoxycillin Trihydrate<br>|<br>za<br>29413010<br>Doxycycline Hyclate<br>|<br>|<br>|<br>[5<br>29414000<br>Chloramphenicol<br>6<br>29419019<br>Cefuroxime Sodium Sterile<br>|<br>po7<br>| -29arg019<br>Clarithromycin<br>|I<br>|<br>8 | 29419030<br>Enrofloxacin<br>||<br>a<br>poe<br>amoxicillin’Sodium &Potassium“fp<br>> 0<br>ess<br>29419090|||||||<br>;|
||Clavulanate|||||||
||<br>10<br>29419090<br>|_<br>Azithromycin Dihydrate|||||||
|||Le 29419090<br>Cefoperazone Sodium<br>| 12 |<br>29419090<br>Ceftriaxone Sodium Sterile|||||||
||<br>||Clavulanate Potassium Diluted —<br>|<br>13 | 29419090<br>—_<br>(Avicel)|||||||
||<br>||| 14|<br>29419090<br>Sulbactam Sodium<br>| 15| 39059990<br>P.V.P.K-30|||||||

axone Sodium Sterile|||||||
||<br>||Clavulanate Potassium Diluted —<br>|<br>13 | 29419090<br>—_<br>(Avicel)|||||||
||<br>||| 14|<br>29419090<br>Sulbactam Sodium<br>| 15| 39059990<br>P.V.P.K-30|||||||
||<br>|<br>|<br>||'Proposed Authorized operations Below:<br>|<br>Sr.no<br>Particulars<br>HSN Code<br>|<br>Doxycycline Hyclate Bp/Ip, -M/S<br>Scott-Edil Pharma, M/S Nem<br>i<br>Laboratories, M/S Theon Pharma, |} 29419090||<br>Annual Capacity<br>(In Qty)||.<br>.<br>Free/Prohibited /Restricted<br>|<br>|<br>Free<br>||||
||<br>||M/S Akums Drugs And<br>Pharmaceuticals|||.||||
|i|||||||
|||60m! Amber Glass<br>Bottle<br>70109000||5000||||
|i|||||||

|

:

;

.

: -

|||ACARBOSE<br>IP, -M/S Theon|||||||
|---|---|---|---|---|---|---|---|---|
|||Pharma, M/S FORGO|||||||
||:|||39329990||ree|||
|||PHARMACEUTICAL, M/S MASCOT|||||||
|||HEATH<br>SERIS P.LTD|||||||
|||Acyclovir Ip,<br>- M/S Fde Ltd, M/S|||||||
|||Arihantanam<br>Lifecare<br>Pvt.Ltd., M/S}||29335990|5000|Free|||
|||Macleods Pharamaceuticals<br>Ltd|||||||
|||Alpha Lipoic Acid, -M/S Akums|||||||
||>|Drugs & Pharmaceutical, M/S.||29349990|5000|Free|||
|||Spansules Pharma, M/S Stabicoat,|||||||
||e||M/S Supreem Pharmaceuticals<br>[7 ominum captorwets |7oiose00<br>Amikacin Sulfate tp, -M/S Aristo<br>Pharma<br>Ltd, Ms/ Macleods||7oiose00|.<br> | sooo ||sme|.<br>||<br> Cd<br>||
|||||29419090||Free|||
|||Pharmaceuticals<br>Ltd., M/S<br>Lifestick|||||||
|||Pharma|||||||
|||Ampicillin Trinydra<br>Te<br>Ip, -M/S|||||||
|||Scott Edil Pharmaceia, M/S<br>Uni |||29411020|5000|Free|||

|||29419090||Free|||
|||Pharmaceuticals<br>Ltd., M/S<br>Lifestick|||||||
|||Pharma|||||||
|||Ampicillin Trinydra<br>Te<br>Ip, -M/S|||||||
|||Scott Edil Pharmaceia, M/S<br>Uni |||29411020|5000|Free|||
||||Medico, M/S Milan Laboratories<br>Amoxicillin Sodium And Potassium|||||||
|||Clavulanate, -M/S Zydus|||||||
||11|Helathcare Ltd, M/S Alkem||30032000||Free|||
|i<br>|||Laboratories, M/S Karanataka<br>Antibiotics Ltd||||||||
|||2|Amoxicillin Trinydrate Compacted, -<br>M/S<br>Milan<br>Laboratories, M/S<br>Scottedil Phamaceia, M/S Medicef||39411030|5000|Free|||
|||Pharma|||||||
|||||||||||
||<br>|<br>||13<br>14|Antipyrine Usp, M/S Intracin<br>Pharmaceuticais, -M/S Safecon<br>Lifesciences, M/S Veko Care<br>Ascorbic Acid Ip, M/S Bajaj<br>}Helathcare, -M/S Rosseta Lifecare,}<br>M/S Kwality Pharma||29331100<br>29362700|5000<br>5000|Free<br>Free|||<br>||
|||15|Aspartam Powder, -M/S Swiss<br>|Pharma, M/S Yash Medicare, M/S<br>Divine<br>Laboratories|.|29242990|5000|Free|||<br>||

|

|

ma||29331100<br>29362700|5000<br>5000|Free<br>Free|||<br>|| |||15|Aspartam Powder, -M/S Swiss<br>|Pharma, M/S Yash Medicare, M/S<br>Divine<br>Laboratories|.|29242990|5000|Free|||<br>||




| 

| 

```text
||||Azithromycin Ip/Usp/Ep, -M/S|||||||i|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|i.|||||||||||||
||<br>Theon Pharma, M/S Hetero Drugs,)||||29419090||5000||Free|||||
|||||M/S Akums Drugs|||||||||,|
||||Aztreonam For Injection Usp (Bulk|||||||||)||
||<br>||| ||17.|Drug )(Dry Mixure For Sterile<br>|Aztreonam & Arginine)- M/S Gmh}|29419090||5000|"Free||||||
||||Laboratories, M/S United Biotech,|||||||||||
||||M/S Oscar Remedies||||||||||
|||||Benzathine Benzvipecillin With 1 %<br>Lecithin Bp- M/S Bharat Pyrental,}|29411099||5000||Free|||||
||nf|nf||P22M7ScJackson Laboratories”22 |-20 coc||eo|ne pti|iii|crete|||et|||
|||||Betamethasone Bp/Ep/Ip/Usp-|||||||i|||
|ae<br>_M/S ZydusCadila,<br>M/S Unison |29372200 | 5000} ree<br>:<br>|<br>Pharma<br>.<br>|__|]<br>20 | ____Bezafibrate<br>ep____|29242990<br>|__sooo |tree<br>tf<br>|<br>|<br>Caffeine Anhydrous lp- M/S<br>|<br>.<br>|<br>Scottedil Pharma, M/S Inga<br>it<br>21<br>;<br>29393000<br>Free<br>Laboratories, M/S Rivpra<br>;|||||||||||||
||<br>|||<br>i<br>|<br>py}|22|Formulation<br>Calcium Pantothenate Ip- M/S<br>Flamingo Pharmaceutical, M/S|29362400||5000||Free|.|i<br>||:||

93000<br>Free<br>Laboratories, M/S Rivpra<br>;|||||||||||||
||<br>|||<br>i<br>|<br>py}|22|Formulation<br>Calcium Pantothenate Ip- M/S<br>Flamingo Pharmaceutical, M/S|29362400||5000||Free|.|i<br>||:||
||<br>|<br>,<br>|||<br>i |<br>|<br>|<br>i<br>||23<br>24|Centurion Healthcare<br>Carbamazepine Bp- M/S Glumex<br>Pharmaceuticals<br>Carbidopa lp- M/S Intas Pharma,<br>;<br>M/S Eurokem<br>Laboratories|29339990<br>29280090||5000<br>5000<br>,||Free<br>Free|||||
|-<br>|<br>|<br>|<br>|||<br>i |<br>|<br>|<br>||25<br>26<br>27|Cefadroxil Usp (Compacted Grade)-<br>M/S Brawn Laboratories<br>Cefalexin Monohydrate Compected<br>Bp- M/S Sai Pyrental, M/S<br>Globela Pharma<br>Cefipirome Sulphate (Sterile) |p-<br>)<br>M/S Protec<br>Telelinks|29419090<br>29419020<br>29419019||5000<br>5000<br>5000||Free<br>Free<br>Free|||<br>.|.<br>;||
|||||||||||||||
||||28|Cefoperazone Sodium<br>(Sterile )Ip/Usp- M/S Karanataka|29419090||5000||Free|||||
||||;<br>Antibiotics, M/S Gepach||||||||||
|||||International,M/SIntasPharma||||||||||
  • : :

|||||||| ||||28|Cefoperazone Sodium<br>(Sterile )Ip/Usp- M/S Karanataka|29419090||5000||Free||||| ||||;<br>Antibiotics, M/S Gepach|||||||||| |||||International,M/SIntasPharma||||||||||




- : : 

```text
|||||29|Ceftazidime For Injection (Bilk<br>Sterile |p)- M/S Pace Biotech,<br>M/S Gmbh<br>Laboratores|29419019|5000|||Free|||
|---|---|---|---|---|---|---|---|---|---|---|---|
||:|||||||||||
|||||Ceftiofur Sodium<br>Sterile (Vet)-||||||||
||||30|M/S<br>Intracin Pharma, M/S|29419019||||Free|||
|||||Bovicure Pharma||||||||
|||||Ceftizoxime Sodium<br>(Sterile)||||||||
||||31|{U.S.P- M/S Safecon Pharma, M/S}|29419019||||Free|||
|||||Intracin Pharmaceuticals|-|||||||
|||||Cefuroxime Sodium Sterile Ip/Usp,|||||||||
||||32||- M/S Scottedil Pharamciea, M/S||29419090||.||Free||||
|||||Laborate Pharmaceutical|||||||||
||||[|Sem mmaein |me | see <br>33<br>29414000<br>Pharma, M/S Rol tndia Ltd<br>Chorionic Gonadotrophin||||||om <br>Free|||<br>i<br>|<br>|||
|||||Ip/Bp(Hcg) Refine Powder Bp.|p-|||||||||
||||34|M/S Gufic Bioscience, M/S|29372100||||Free||||
|;|||||Sanzyme Ltd|||||||||
||| <br>|<br>||<br>|<br>|||| 35<br>[+ <br>37.|29419030<br>Labotories,.

|||||Ip/Bp(Hcg) Refine Powder Bp.|p-|||||||||
||||34|M/S Gufic Bioscience, M/S|29372100||||Free||||
|;|||||Sanzyme Ltd|||||||||
||| <br>|<br>||<br>|<br>|||| 35<br>[+ <br>37.|29419030<br>Labotories,. M/S Cadila Pharma<br> |imenewm manere PAME| -<br>Pharma, M/S Sunvet Healthcare<br>Clarithromycin Ip Usp- M/S<br> | Saphnix Lifescienes, M/S Shukra | 29419090<br>5000<br>Pharmaceutical<br>Clavulanate Potassium Diluted<br>)<br>(Clavulanate Potassium|||||Free<br>|<br>|<br> me<br>|<br>|<br>Free<br>|||||
||||38|Microcrystalline- M/S Maxim|29419090|5000|||Free|||
|||||Pharma, M/S Bonsai Pharma,||||||||,|
|||||M/S Unimedico|||||||||
|||||Clavulanate Potassium Diluted|||||||||
||<br>|<br>|<br>||||39|(Clavulanate Potassium Silicon<br>Dioxide){!:!) Ip- M/S<br>Finecure<br>Pharmaceuticals, M/S Nestor<br>Pharmaceuticals|29419090|5000||.|Free|i<br>|<br>|<br>|||
|||||Clindamycin<br>Hydrochloride<br>Ip,<br>-||||||||
||||40|M/S Sanjivanee Pharma, M/S|29419019|5000|||Free||||
|||||Intas Pharma<br>.|||||||||

ticals|29419090|5000||.|Free|i<br>|<br>|<br>||| |||||Clindamycin<br>Hydrochloride<br>Ip,<br>-|||||||| ||||40|M/S Sanjivanee Pharma, M/S|29419019|5000|||Free|||| |||||Intas Pharma<br>.|||||||||




```text
|||||41|||Clindamycin Phosphate Ip- M/S<br>Intas Pharma|29419040||5000|Free||<br>|<br>i||<br>|<br>i|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||Colistimethate Sodium Ep|29419090||5000||||
|{||||||||||||-|
|||||||Cynocobalamin (Vitamin B12) Ip | 29362610|||5000||||
||<br>|||i; <br>|<br>|||| 46<br>47||D-Calcium Pantothenate<br>Dexamethasone Sodium Phosphate<br>Ip- M/S Intas Pharma<br>Dicyandiamide 99.7 Pct Min- M/S||29362990<br>29379090<br>29262000||5000<br>5000|Free<br>Free||||
||||48|||Socomed Pharma, M/S Emil|29331999||5000|Free|||
|L- -_-— —.- —_-|- —— — ee<br>|<br>|<br>COU|49<br>|||||||—a ~“Pharma-~ —ee ee <br>Echinocandin B Cycle-Peptide<br> NucleusHydrochloride<br>Salt<br>(Ecbn. Hcl)|er<br>a<br>—— |= = = = ‘ -—_—-——<br>|29349990|5000[|——Free |po||||||
|||||||Enoxaparin Sodium Ip- M/S Intas<br>Pharma||29420096|||Free||<br>i]<br>||-|
||||51|||Erythromycin Thiocyanate Hplc|29415000||5000|Free|i|.|
|||;||||Grade||||,|||
|||<br>|||52||Bulk)-|Faropenem Sodium (Non-Sterile<br>Bulk)- M/S Supermax Drugs And <br>Pharmaceuticals<br>Fluorouracil Ip|||29420090<br>29335990 |||5000<br>__5000|Free|i<br>|<br>i||
||||54||Fosfomycin Sodium Ep- M/S Bdr||29419019||5000|Free|||
|||||||Pharmaceutical|||||||
|||<br>|<br>|||55||Furazolidone- M/S Haffkine Ajintha<br>Pharmaceutical||29349200||5000|Free|||

<br>|<br>i||
||||54||Fosfomycin Sodium Ep- M/S Bdr||29419019||5000|Free|||
|||||||Pharmaceutical|||||||
|||<br>|<br>|||55||Furazolidone- M/S Haffkine Ajintha<br>Pharmaceutical||29349200||5000|Free|||
|||<br>|||56|||Gentamicin Sulfate Ip- M/S<br>;<br>Skymap Pharmaceuticals|29419040||5000|Free|||
|||<br>|<br>|<br>|<br>|<br>|<br>|<br>|<br>©||57<br>59<br>[eo|||Gliclazide Bp/Ip- M/S Lok Beta<br>;<br>Pharmaceutilcas<br>Griseofulvin Ip/Bp- M/S Ajanta<br>Pharma<br>Heparin Sodium Ip/Usp- M/S<br>;<br>Pace<br>Biotech<br>yaturonic act|29420090<br>29419090<br>30019091<br>39139090 ||:|5000<br>5000<br>5000<br>sooo|Free<br>:<br>Free<br>Free<br>|~SOweeSSS*«dYdSCCS<br>£|||
|||||||||||||||
|||||||||||||||
|||||||||||||||

:

: ,

, ;

.

;

|||Hydrocortisone Acetate Bp Ip- M/S|29379090|5000|||Free|||
|---|---|---|---|---|---|---|---|---|---|
||Zydus Cadila Pharma<br>a2|<br>wvPROMELLOSE {Kloom) | <br>indomethacin Ep/ip |||39123929 |<br> 29339900 ||5000<br>5000||;||||
||67|L-Carnitine -L-Tartrate- M/S Zydus<br>Cadila Pharma|29239000||||Free||||
|||Levamisole Hydrochloride {Vet<br>) tp<br>”|29343990||||Free|;||
|||7Ep||||||||
|||Levodopa<br>[p- M/S Intas Pharma|29225090|5000||||||
|||Levofloxacin Hemihydrate<br>Ip- M/S||||||||
||71||29349990||||Free|||
|||Cadila Pharmaceuticals|||||||||
||72|Levomisol Hydrochloride Ip Bp-<br>M/S Karnatak Antibiotics|29349990|5000|||Free|||<br>||
||73|Lincomycin<br>Hydrochloride Usp/lp-<br>”<br>”<br>an<br>M/S Carewin<br>Pharmaceuticals|29419090||||Free||||
|||76|Mecobalamin- M/S Intas<br>Pharmaceuticals, M/S Supreem|29362690|5000|||Free|||

||
||73|Lincomycin<br>Hydrochloride Usp/lp-<br>”<br>”<br>an<br>M/S Carewin<br>Pharmaceuticals|29419090||||Free||||
|||76|Mecobalamin- M/S Intas<br>Pharmaceuticals, M/S Supreem|29362690|5000|||Free|||
|||Pharma|||||||||
||77|Menotrophin Bp/Usp {Hmg)<br>Refine Powder Bp Usp|29371900||||Free||**|**<br>||
||||Meropenam With Sodium|||||||||
||78||Carbonate Sterile Usp- M/S United}|29339990|5000|||Free||||
|||Biotech, M/S Pace Biotech|||||||||
|||Metamizole Sodium Ep|29331990|5000||||||
|| <br>||Fat |Methylprednisolone|Methylprednisolone Ip/Bp/Usp/Ep}<br>Metronidazole Ip/Bp- M/S|29371900|5000|;||||||
||82|Intermed Laboratories, M/S|29332920||||Free||||
|||Jackosn Laboratories|||||||||
||||||||||||
||||||||||i|

|pOa|pOa|pOa|pOa|pOa|pOa|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|||Mifepristone Ip- M/S Akums Drugs<br>83<br>& Pharmacueticals, M/S Accent ||||29372900||||Free||<br>i|.|
||||Pharmaceutical & Diagnostics|||||||||
||||Misoprostol Dispersion- M/S Mepro||||||||||
|||84|Pharmaceutical, M/S G.D||29379090||||Free|||
|||Laboratories, M/S Sterile Gene<br>Life||||||||||
||||Naproxen Sodium Usp- M/S||29189990|5000|||Free|||
||||Flamingo Pharmaceuticals<br>—|||||||||
|J<br>-.--<br>po||ry<br>A<br>epee|Neomycin Sulphate Ip- M/S<br>nn | <br>de<br>Curetech “Skincare ~~"<br>*|29419050}...<br>5000... <br> 7°<br>Te||||...

ee|||
||||Flamingo Pharmaceuticals<br>—|||||||||
|J<br>-.--<br>po||ry<br>A<br>epee|Neomycin Sulphate Ip- M/S<br>nn | <br>de<br>Curetech “Skincare ~~"<br>*|29419050}...<br>5000... <br> 7°<br>Te||||... Free<br>Tee||||<br>fee<br>ap||
|pose —~--.-4 <br>i|<br>89|||-- Norefloxacin Ip-M/S-kaborate-- |----ee<br>Pharmaceuticals, M/S Infinity<br>29335930|||ne<br>5000||ee ee<br>eeeee ee -.| ee<br>Free<br>||||ee ee|
|———}ff<br>|<br>|<br>|<br>i<br>|<br>|||ff|en 061 000 a<br>Nystatin Usp- M/S Mcw<br>Healthcare|rr<br>29420090|||||Free|—|t————<br>i<br>|||
||<br>|||<br>|<br>|||Oxytetracycline Hydrochloride Vet<br>lp/Bp/Usp/Ep<br>Para Chloro Benzaldehyde 99%||29413020<br>|<br>29130030|5000<br>5000||||Free|i}<br>os|-|
|||i { 94<br>|<br>[95|<br>| | 96 | <br>|<br>| | 98 |||Paracetamol Bp- M/S<br>Tiruvison<br>.<br>Medicine<br>__Photoiniiatorn73<br> Piracetam Ip- M/S Pace Biotech | <br>Prednisolone Ip2014/Ep9/Usp40 | <br>Progesterone Bp/ip||29242930<br>29143990 |<br> 29337990<br> 29372100<br>29372300|5000<br>5000<br>5000<br>5000<br>5000|||Free|J<br>|||
||||||||||||.|
||||Pyridoxine Hydrochloride (Vitamin||29362500|5000|||Free|||
||||B6)|||||||||
||||||||||||||
|||||Rifampicin Ip- M/S Unicure<br>Remedies||29419011|5000|||Free||.<br>.|
||<br>1<br>||||Roxithromycin Ep- M/S Prochem<br>ao<br>Pharmaceuticals||29419090|5000|||Free|||

.

.

;

|||||||||| |||||Rifampicin Ip- M/S Unicure<br>Remedies||29419011|5000|||Free||.<br>.| ||<br>1<br>||||Roxithromycin Ep- M/S Prochem<br>ao<br>Pharmaceuticals||29419090|5000|||Free|||




. 

. 

; 

```text
|||||Sodium Ascorbate- M/S Radicura|Sodium Ascorbate- M/S Radicura||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||29362990||||Free|||
|||||;<br>Pharmaceuticals|||||||||
||||107|Spironolactoneip- M/S tpca||29322090||5000||Free|||<br>i|
|||||.<br>Laboratories|||||||||
|||||Sterile Mixture Of Meropenem And||||||||||
|||||Sodium Carbonate- Ms Venus<br>Remedies||29419090||||Free||||
|||||Streptomycin Sulfate Non-Sterile||29412010||5000||Free|||
|||||(Vet}Ip/Bp/Ep|||||||||
|||||Sucralfate Ip /Usp- M/S Dr’reddy<br>mo<br>we<br>es<br>=<br>Laboratories||29AOOOOO||5000|~|Free|co||
|||||Sulbacatam Sodium |Ip/Usp- M/S||29419019||5000||Free|||
|||||;<br>Cadila<br>Pharmaceuticals|||||||||
||||113|Telmisartan Ip- M/S-Jackosn||29339900||||Free|||
|||||Laboratories|||||||||
|||||Thiamine Hydrochloride (Vitamin|Bl||||||||
|||<br>|||115|Hydrochloride) Ip- M/S Biocera|| 29362210|||||Free|||
|||||Pharmaceuticals|||||||||
|||||Thiamine Mononitrate (Vitamin<br>Bl|||;||||||
|||||Mononitrae<br>)lp- M/S Centurion||29362210||5000||Free|||
|||||Healthcare|||||||||
|||||Tranaxamic Acid<br>Ip||29420090||5000|||||
||||122|Urofollitropin Bp/Usp-Nf(Fsh)||30043990||5000||Free|||
|||||Refine Powder|||||||||
||||||Ursodeoxycholic Acid Ip||29181690||5000|||||
||<br>t||||125|Vancomycin Hydrochloride<br>( Bulk<br>Sterile)Ip/Usp||29419090||5000||Free|||

43990||5000||Free||| |||||Refine Powder||||||||| ||||||Ursodeoxycholic Acid Ip||29181690||5000||||| ||<br>t||||125|Vancomycin Hydrochloride<br>( Bulk<br>Sterile)Ip/Usp||29419090||5000||Free|||




| Vitamin B12 (Cynqgobalam..I-N)} | fy 128 rerane-ferast a TH, Alafia aA SEZ aaa’ Decision= Aner deliberation, thee Committee | : 2006 & faa 19 (2) & ded, SR seams TS aeq3ait =APProved C ihe proposal of M/s.Aquaticquatic Remed les | & at & Gis. aise rearea Q) acqai wr sisal-_ asLimitedmentionedfor Additiab **o** nve(Broadin termsBanding)of Ruleof19list(2) ofof items SEZ — - | M/s. Aquatic Remedies Limited & Urea I FART Pie. 2006 with consensus of the Specified Officer, & al we Ask, aeqait i ueaiad sis dS % JNPA SEZ for proposed broad banding of items. Hay A INPA SEZ ‘Tetfee sirens’ (Specified Officer) HY Geafa & areny uy at as FI | SLR #08) ATTA AA hl .[zis] a Hel =o Agenda Item No. 05: Proposal of M/s. Sole Bloom aFe eg ort on ONT? SST SEZ Private. Limited. (Manufacturing) located at | nS oo oo ~ So , ' JNPA-SEZ for approvalw.rt:Changeof Name of ~~ their company. ooo gre + ate oat & art uRada & fety vp ade4 The unit had submitted an application for Change — ; > Reger febaremr-guey faaxur PATGAR 1 ~~ ~~~ ofindicated Namebelow.of -their company- ‘The -details-are- as-----

## | 

. 

| \ i 

**==> picture [313 x 305] intentionally omitted <==**

**----- Start of picture text -----**<br>
a. Change in Name:<br>"FromM/s. Sole Bloom SEZ Private| M/s. Global Trade tf<br>; Limited. Gateway Private Limited. |<br>b. The details of Existing in Shareholding Pattern:<br>Name of the| Type | No. of| Total |Amount} % of<br>shareholder| of |shares|Amount| of share<br>shares (in Rs) | Share |holding<br>i Capital<br>Mr. Siddhant| Equity 10 5% |<br>Kumar Jain<br>Mr. Yash | Equity 9500 | 95% |<br>Gangwani<br>Ram<br>TOTAL | | tooo 10,000 | 100% |<br>**----- End of picture text -----**<br>


c. The details of Existing in Board of Directors: 

. 

; 

**==> picture [2 x 1] intentionally omitted <==**

**----- Start of picture text -----**<br>
.<br>**----- End of picture text -----**<br>


; 

. 

**==> picture [287 x 62] intentionally omitted <==**

**----- Start of picture text -----**<br>
Existing list of Board of Designation<br>Directors<br>| 4. | Mr. Siddhant Kumar Jain.<br>(2. [Wir- Yash Gangwani Ram | [Director] |<br>**----- End of picture text -----**<br>


. 

i 

|

----**<br>
Existing list of Board of Designation<br>Directors<br>| 4. | Mr. Siddhant Kumar Jain.<br>(2. [Wir- Yash Gangwani Ram | [Director] |<br>**----- End of picture text -----**<br>


. 

i 

| 

Pula: freq frareforet & saris, affa 7 Aa diet Decision: After deliberation, the Committee ea Ast wigde fetes (rathraRt) o we GI, approved the proposal of M/s. Sole Bloom SEZ Trak ts ang & Peer dea 109 feria 18.10.2021 Private Limited (Manufacturing) for Change in far& Maal & ced, ort AT cer Pees F uRada¢& Name of their company in terms of MoC& ett aapifedDT OTe oxfea fen, sentSITET fs sm fade 4 sfefsa toinstructioncomplianceNo. of109thedatedconditions18.10.2021mentioa **n** edd subjectin the said instruction. "WEST Fa S06: SATSora fear Fag alet a Agenda Item No. 06: Proposal of M/s. Sole Bloom "igen 8 chortt Sy are aRacleby arqatert 8a] SEZ Private Limited (Warehousing Activity) located at JNPA-SEZ for approval w.r.t. Change in Name of their company. sors F aot Host sik Fea & aH aRadT & fet? The unit had submitted an application for Change Sede Tega fran ent six feraeor ster fer re EI of Name of their company. The details are as indicated below. 

**==> picture [592 x 447] intentionally omitted <==**

ubmitted an application for Change Sede Tega fran ent six feraeor ster fer re EI of Name of their company. The details are as indicated below. 

**==> picture [592 x 447] intentionally omitted <==**

**----- Start of picture text -----**<br>
i d. Change in Name: |<br>[0 ree te 7 ,<br>| ' || M/s. Sole Bloom SEZ Private M/s. Global Trade |<br>| | Limited. Gateway Private Limited. |<br>|<br>e. The details of Existing in Shareholding Pattern: |<br>|<br>Name of the| Type | No. of | Total |Amount! % of<br>| |shareholder| of |shares|Amount| of share |<br>(INR) |<br>| Capital |<br>|.... |L|Mr.Siddhant| Equity} 50 |_.10 _|_.500 | 5%__ , ee ee<br>Kumar Jain |<br>2.| Mr. Yash | Equity} 950 10 9500 | 95% |<br>———|---Gangwani-} -- - —-}-—-]-----]4 en nn nn<br>| Ram<br>| TOTAL [Total | 1000 | 10,000 | 100% |<br>];i<br>| | f. The details of Existing in Board of Directors:<br>| Existing list of Board of Designation |<br>| Directors |<br>Mr. Siddhant Kumar Jain<br>Mr. Yash Gangwani Ram<br>**----- End of picture text -----**<br>


| og Bat vigde fees (cerershar Tiefefet) & wT approved the proposal of M/s. Sole Bloom SEZ. | or wat ww ag & Rex Wei 09H Private Limited (Warehousing Activity) for Change | 18.10.2021 % waar & ced, eo] & AM del in Name of company, in terms of MoC&t instruction | free4 oRacs a fay apie ax fear, aed fe GH No. 109 dated 18.10.2021 and subject to | fréer 4 sfeaaeral or arqurerst fer SET | compliance of the conditions mentioned in the said instruction. 

. 

; 

;

e4 oRacs a fay apie ax fear, aed fe GH No. 109 dated 18.10.2021 and subject to | fréer 4 sfeaaeral or arqurerst fer SET | compliance of the conditions mentioned in the said instruction. 

. 

; 

; 

aoWisttisdeFe ¥_O7:fatesIT(efer eatafefatey H feta& waneARR aa& deer sel F Agenda Item No.a 07: Proposal; of M/s._ Sole Bloom : court 3 ara URada o SrA og SEZ Private Limited (Trading Activity) located at JNPA-SEZ for approval w.r.t. Change of Name of their company. 

' garg 4 at dot sik Peer & ars oRada & fey STS Wega feoar ar! sie feaeor her fae Te FI 

The unit had submitted an application for Change of Name of their company. The details are as indicated below. 

```text
|||g.<br>Change in Name:||||
|---|---|---|---|---|---|
|||||i||
||||M/s. SoleBloomSEZ Private<br>M/s. GlobalTrade<br>Limited.<br>Gateway Private Limited.|||||
|||h.<br>The details of Existing in Shareholding Pattern:||||
||||||||
|||Name ofthe} Type | No. of}<br>Total||Amount}<br>% of|||
|||shareholder;<br>of<br>j{shares|Amount!|of<br>share|||
||<br>|.)<br>;<br>|<br>|<br>|||shares<br>{in Rs) <br>Mr. Siddhant| Equity<br>10<br>Kumar Jain<br>Mr.Yash_ |Equity<br>10<br>| Gangwani<br>Ram||Share<br>|holding|<br>Capital<br>|<br>(INR)<br>500 | 5%<br>|<br>9500 | 95%<br>||||
||||i. Thedetailsof ExistinginBoardofDirectors:|||||
||||||||
|||<br>||Existing list ofBoard of<br>Designation<br>Directors<br> | 4. | Mr.Siddhant KumarJain |Director|<br>2.| Wir.Yash GangwaniRam||||
|||||||||

==> picture [1 x 32] intentionally omitted <==

||Existing list ofBoard of<br>Designation<br>Directors<br> | 4. | Mr.Siddhant KumarJain |Director|<br>2.| Wir.Yash GangwaniRam|||| |||||||||




**==> picture [1 x 32] intentionally omitted <==**

**----- Start of picture text -----**<br>
|<br>**----- End of picture text -----**<br>


**==> picture [2 x 15] intentionally omitted <==**

**----- Start of picture text -----**<br>
.<br>**----- End of picture text -----**<br>


| 

| | | 

| 

| 

| Pola:sa Ue faeqa frarfaastwigde feiies &(efsr oia,afcfafe) aPifd 7&a Atweda UetGI, ~Decision:eeapproved the Afterproposaldeliberation,of M/s. Solethe BlC **o** mmitteeomoeSEZ | waa wd aig & cer wea 109 fei 18.10.2021 Private Limited (Trading Activity) for Change in. || fery&STAUa CTargifear SITUTSA& ced,ax fearfeen,SoGATTaert& ar **t** focenGenPresenfide ¥4oRaiatwferfet¢& complianceNo.~=Name109of company,datedof the conditions18.10.2021in terms mentionedof MoC&land subjectininstructionthe saidto. instruction. | Quist &t Fret af 2020-21 8 2024-25at arate & fer performance of M/s. Simosis International for the | He We 08: Feet MAA sowleMtet & Wash Agenda Item No. 08: Monitoring of the period 2020-21 to 2024-25. ft a¥ 2020-21 4 2024-25 A safe a fey afte ane Ana oe a oemanes by seb Sr me ome 9) -25 was received from Specifie icer, a Fra Rate (AER) Oe OG3 Ae ane JNPA SEZ on the-basis of APR submitted by the | lon), Guahivada A Ree 4 eae Par var 2 [> Unit. The report of Specified Officer, JNPA-SEZ | Earnings) 518 fear[|] 2024-25 po Foie: fede frar-fore & savic, afta + Ga Fas, Decision: After deliberation, the Committee noted .

4 eae Par var 2 [> Unit. The report of Specified Officer, JNPA-SEZ | Earnings) 518 fear[|] 2024-25 po Foie: fede frar-fore & savic, afta + Ga Fas, Decision: After deliberation, the Committee noted . of Rule 54 SEZ Rules, 2006 | 2006 FUrl 54 & HINT & SFE aT FATA performance of M/s. Simosis International in terms i | doa HEAT BY GTSSA The Meeting concluded with a vote of thanks to the chair. | eb UTE SATE EE } 

DigitallyDate: 2026.05.12 signed Sr71:36:55DlyaneshwarIST Patil 

Shri. Dnyaneshwar B Patil Development Commissioner SEEPZ- SEZ 

| 

**==> picture [3 x 2] intentionally omitted <==**

**----- Start of picture text -----**<br>
-<br>**----- End of picture text -----**<br>


. 

; 

| . | ; . | | | 

. 

. 

Action Taken for Approval Committee held on 28-04-2026 

- 

**==> picture [507 x 282] intentionally omitted <==**

**----- Start of picture text -----**<br>
```text
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Confirmation|of the|Minutes|of the|69th|
|eee eee|NG.|[Meeting held on 24-03-2026|_||
|Agenda|item No.|©|___|Onnsynex||Application Ventures for setting Private up ofa Limited.new unit(M/s.|LOA|issued;|"|oat.|oe|
|Application|for Addition|of|Location(M|/s.|.|.|
|[beens Hem|NO- OF|[isApplic Aqu|ati|onc|forRemedies BroadLimited)—|Banding of|Items(M[Preval|eterissuedotheunit.|.|||
|Application|for Change|ofName(M/s.|Sole|
|Agenda ItemNo.05~|{Bloom SEZ Private Limited|(Manufacturing)|Approval Letter issuedto|the unit|“~~|
|D|
|||Application|for Change|of|Name(M/s.|Sole|oe|

.|||
|Application|for Change|ofName(M/s.|Sole|
|Agenda ItemNo.05~|{Bloom SEZ Private Limited|(Manufacturing)|Approval Letter issuedto|the unit|“~~|
|D|
|||Application|for Change|of|Name(M/s.|Sole|oe|
|Agenda Item No.|06|Bloom SEZ|Private|Limited|(Trading|Approval|Letter issued to the unit|
|:|
|Application|for Change|ofName(M/s.|Sole|}|
|Agenda Item No.|07|Bloom SEZ Private|Limited (Warehousing|[Approval|Letter issued to the unit|
|Application|for Monitoring|of|ae|||
|Hoenn|eno.|___[Rerformance(Mi/s.Simosis Intemational)||Monovins Performance|was|noted,|

----- End of picture text -----<br>

GOVERNMENT OF INDIA, OFFICE OF THE DEVELOPMENT COMMISSIONER, SEEPZ SPECIAL ECONOMIC ZONE, GOVT. OF INDIA, ANDHERI (EAST), MUMBAI

.

;

.

. . ,

.

.

:

AGENDA NOTE FOR CONSIDERATION OF APPROVAL COMMITTEE

a. Proposal:

The proposal of M/s. SRS Pharmaceuticals Private Limited for carrying out Manufacturing activities of various Pharma Items and Research & Development Services, as detailed in Annexure “A”, over an area admeasuring 8,500 Sq. Mtrs. at Plot No. 603, Sector-6, JNPT SEZ, developed by JNPT, Uran, Navi Mumbai — 400702.

|

==> picture [475 x 568] intentionally omitted <==

----- Start of picture text -----<br> _ b._ Specific Issue on which decision of AC isrequired:- = msn .<br>Rule 17 & 18 of SEZ Rule, 2006.<br>c. Relevant provisions of SEZ Act, 2005 & Rules, 2006/Instruction/<br>Notification :-<br>Application for Setting up up ofNew UnitNew Unit Unit at JNPA-SEZ JNPA-SEZ by M/s. SRS Pharmaceuticals Private Limited for carrying<br>Manufacturing activities of various various Pharma Items and Research & Development Research & Development & Development Development Services.<br>d. Other Information: -<br>Proprietorship’ PartrershipHndividuel/Pvt. Ltd. Company<br>Status ofthe company<br>partnership/Individual<br>and statute under ae -<br>which registered U2423MH2001PTC131384<br>with registration no.<br>Item(s) Description CPC Code Capacity Units<br>| [No.] Sr. ss fe aS)” . | .

ny<br>partnership/Individual<br>and statute under ae -<br>which registered U2423MH2001PTC131384<br>with registration no.<br>Item(s) Description CPC Code Capacity Units<br>| [No.] Sr. ss fe aS)” . | . |<br>yO Sodium Hydrogencarbonate (Sodium .<br>| | | Bicarbonate / Baking Soda) | 28363000} 140000.00 | _Nos<br>i | Medicaments containing hormones or<br>2 | other products of Heading 2937, not | 30043919] 360000.00 Nos<br>containing antibiotics — Other<br>Product | 3 | Other Prgbestogen and Oestogen | 30043919 | 5280000.00 | Nos |<br> to be | oupssesmoe’s<br>manufacturing to be || Antihistaminic drugs; Antacids<br>d rendered in Form F H preparations; Antiulcer drugs;<br>| 4 jAntiemetics and other Gastrointestinal] 30049034} 70000.00 Nos<br>drugs, including Omeprazole and<br>| Lansoprazole<br>Other medicaments for therapeutic or<br>| 5 | prophylactic use, put up in measured | 30049099 | 34330000.00 | Nos<br>| doses or retail packs !<br>Research ;<br>6 and Data & Processing Development in Medical Services 998113 / 1.00 US |<br>; 8510 Dollar fj<br>Sciences and Pharmacy<br>i fre<br>~ JINPT, Uran, Navi Mumbai — 400702.<br>| [PN] sed ocanen ot Admeasuring 8,500 Sq. Mtrs. at Plot No. 603, Sector-6, JNPT SEZ, developed by<br>----- End of picture text -----<br>

Application for Setting up up ofNew UnitNew Unit Unit at JNPA-SEZ JNPA-SEZ by M/s. SRS Pharmaceuticals Private Limited for carrying out Manufacturing activities of various various Pharma Items and Research & Development Research & Development & Development Development Services.

. -

\ |

ceuticals Private Limited for carrying out Manufacturing activities of various various Pharma Items and Research & Development Research & Development & Development Development Services.

. -

\ |

||||Details **o**f<br>Di<br>etails fDirectors|AnuradhaGaneshNaik<br>Director<br>|<br>SuchetShyamsunderRastogi<br>Director<br>|<br>PoojaKetanDeshpande<br>Director||<br>|<br>||,|
|---|---|---|---|---|---|
|||||| Sr.<br>| Typeof | Amount | No.of |%ofShare<br>| No. Nameof theShareholder<br>shares<br>(Rs.)<br>Shares<br>holders|||
||||Detailsof<br>Shareholding<br>Patt<br>areholding Pattern||<br>1. | AnuradhaGaneshNaik<br>| Equity<br>| 49,49,999|49,49,999|<br>98.99<br>| 2.<br>SuchetRego<br>| Equity<br>|<br>50,000<br>50,000<br>1.00<br>| 3. | PoojaKetanDeshpande<br>| Equity<br>|<br>1<br>|<br>1<br>0.01|H||
|i||i<br>—WiCost<br>ofProject<br>re<br>7<br>7 <br>|||re||
|pout<br>je<br>=<br>ee ee<br>+—_—-—-|-——Preject-Cost-——— [-==-Constraction<br>:<br>|<br>;||||<br>Amount<br>Particulars<br>,<br>|<br>aece<br>eee ee<br>Le<br>~ (Rs. Tn Las) =f<br>|<br>LandCost<br>|<br>594.75<br>|<br>——Preject-Cost-——— [-==-Constraction Cost(Givi, Bleotricaly Mechanical—-——|——-297,36 |a<br>|<br>Computer,Softwares,Licenses(100%Indigenous)<br>60.00<br>|<br>|<br>OfficeCapitalGoodsincludesAVEquipments,PA<br>|<br>182.99<br>|<br>Plantand Equipment’s including materialhanding(80%<br>320.23<br>)<br>indigenous&20%Imported)<br>,<br>.|||
||||Total<br>1,455.32|||
||||i’Means ofFinance:|||
||<br>|||<br>|<br>||Sourceoffunds|/<br>Proposed Amount<br>| Sr.No.<br>Particulars<br>!<br>(Rs.

r>320.23<br>)<br>indigenous&20%Imported)<br>,<br>.|||
||||Total<br>1,455.32|||
||||i’Means ofFinance:|||
||<br>|||<br>|<br>||Sourceoffunds|/<br>Proposed Amount<br>| Sr.No.<br>Particulars<br>!<br>(Rs. In Lacs)<br>|<br>1<br>FromExistingReservesand Surplus/Own<br>1404.32<br>|<br>|<br>funds<br>|<br>2<br>|<br>FromInternalAccruals<br>51.00<br>|<br>Total<br>1455.32|!<br>|||
||<br>|||InvestmentDetails|——————————EE<br>[ Sr.No. |<br>Particulars<br>Rs.InLacs<br>(a)<br>|<br>Plant&Machinery<br>|<br>(69)<br>Indigenous<br>759.92<br>|<br>(ii)<br>ImportCIFValue<br>100.64<br>|<br>Total (i)+ (ii)<br>860.56||<br>|<br>|<br>|<br>|||
||||(Rs, InLacs)|||
|||<br>|<br>|<br>|<br>||I<br>hind<br>miport & indigenous<br>requirementof<br>materialsandother<br>inputs|[|<br>|<br>Import<br>|<br>Indigenous<br>,<br>|<br>(a)<br>CapitalGoods<br>|<br>100.64<br>|<br>759.92<br>|<br>(b)<br>InputServices<br>|<br>150.00<br>[2700.00<br>RawMaterial,Components,<br>| (¢)<br>Packingmaterialfueletc.for5sear<br>412**.**50<br>7837.50<br>|<br>Total<br>|<br>663 14<br>|<br>1297.42<br>SS|_|||

i

' . ,

°

,

==> picture [482 x 670] intentionally omitted <==

)<br>Packingmaterialfueletc.for5sear<br>412**.**50<br>7837.50<br>|<br>Total<br>|<br>663 14<br>|<br>1297.42<br>SS|_|||




i 

' . , 

° 

, 

**==> picture [482 x 670] intentionally omitted <==**

**----- Start of picture text -----**<br>
Employment Projections for Next 5 Year<br>Sr.No.| Particulars [18t year} 294 | 3°¢ year | 4" Year | 5 Year<br>' . Year<br>. A | Skilled and Semi- 9 11 30 50 90 )<br>Total empl ' Skilled H<br>otal employmen Employees | |<br>B Indirect 50 | 35 35 35 35<br>Employees<br>| Total Employees| 59 46 | 65 | 85 | 125 |<br>j<br>(Rs. in Lacs)<br>yo oe | FOB Value of ‘| Foreign Exchange E a rome -<br>Details Exports in first five | Outgo for the first enangee Sarnings<br>years five years for the first five years<br>(1)—(2)<br>Foreign Exchange 15t Year | 500.00 | 119.39 | 380.61<br>Balance Sheet {ond Year | 1500.00 | 56.25 | 1443.75<br>314 Year | 3500.00 | 131.25 | 3368.75<br>4) Year | 4000.00 | 150.00 3850.00<br>| | 5th Year 5500.00 | 206.25 5293.75<br>| Total 15000.00 | 663.14 14336.86<br>| Total (S in 15957.45 705.47 15251.98<br>thousands)<br>The applicant has mentioned that, for marketing of products from the<br>i proposed SEZ Unit, they will establish a separate dedicated marketing department<br>F ifor reaching out to prospective customers. They regularly participate in national and<br>Marketing . .<br>stratesy/buyback plan international exhibitions and trade fairs for enhancing brand visibility, generating<br>eye P business leads, and expanding their global customer base.

l and<br>Marketing . .<br>stratesy/buyback plan international exhibitions and trade fairs for enhancing brand visibility, generating<br>eye P business leads, and expanding their global customer base. Further, they will focus<br>on strengthening relationships with existing clients and exploring new export<br>j markets to ensure sustainable business growth from theproposed SEZ Unit.<br>M/s. SRS Pharmaceuticals Private Limited (SPPL), incorporated in March 2001, is<br>an innovation-driven healthcare company engaged in pharmaceutical<br>manufacturing and Research & Development (R&D). With origins dating back to<br>1995, the company offers a diverse portfolio including antibacterial, anti-retroviral<br>(Anti-AIDS), herbal, and patient-centric healthcare solutions.<br>SPPL commissioned a state-of-the-art oral solid dosage manufacturing facility in<br>Palghar District in November 2023 and established a DSIR-approved R&D Centre<br>Other . : at Rabale, Navi Mumbai in March 2023. The R&D Centre specializes in<br> information formulation development, analytical development, API research, custom synthesis,<br>stability studies, impurity profiling, and regulatory support for international<br>j markets such as the UK and the USA.<br>The company focuses on innovation-driven, affordable, and accessible healthcare<br>solutions, particularly for emerging and underserved markets. SPPL has also<br>developed patient-centric innovations such as an Al-enabled stethoscope,|<br>chewable antibiotic formulations, and tablet-based oral suspensions to improve]<br>patient compliance and accessibility.

r>developed patient-centric innovations such as an Al-enabled stethoscope,|<br>chewable antibiotic formulations, and tablet-based oral suspensions to improve]<br>patient compliance and accessibility. |<br>**----- End of picture text -----**<br>


: | 

**==> picture [597 x 177] intentionally omitted <==**

**----- Start of picture text -----**<br>
```text
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||__|oe|
|||ye|It|is|observed|thatthe|Unit|was|granted|LOA|No.|SEEPZ/NEWSEZ/JNPT-|
|i|SEZ/SRSPPL/34/2022-23/21040|dated|09.12.2022|for|carrying|out trading|
|||activity over an area of 10,200|sq. mtrs. valid up to|08.12.2023.|
|7|Subsequently,|M/s.|SRS|Pharmaceuticals|applied|for deletion|of|8,500|sq.|
|mtrs,.|area|from|the|approved|LoA|for|proposed|manufacturing|activity|and|to|.|
|use balance|1700|Sq mir|for trading|activity.|The|same|was|approved|by|approval|
|committee|and informed to unit vide letter dated 07.04.2025.|
|Observation|
|The|proposal|has|now|been|submitted|by|the|unit|for|setting|up|a|new,|
|same|location.|j|
|||Manufacturing unit over the said deleted/diverted area of 8,500 Sq. Mtrs. at the||
|||Further,|LoA|No.|SEEPZ/NEWSEZ/JNPT-SEZ/SRSPPL/34/2022-23/21040|of|
|the unit for trading|activity has|expired on|08.12.2026.|

----- End of picture text -----<br>

e. Recommendation:

Proposal of M/s. SRS Pharmaceuticals Private Limited for setting up of unit for Manufacturing activities ofvarious Pharma = = Items and Research & Development Services, over an area admeasuring 8,500 Sq. Mtrs. at Plot No. 603, Sector-6, JNPT SEZ, developed by JNPT, Uran, Navi Mumbai — 400702. is placed before the Approval Committee for consideration in "termsof Rule 17 & 18 of SEZ Rules, 20060 eenn WRG RIE RK KR RRERERREE EERE REE RRR IE . .

i | | i

. ,

; |

;

: GOVERNMENT OF INDIA, | OFFICE OF THE DEVELOPMENT COMMISSIONER, : SEEPZ SPECIAL ECONOMIC ZONE, GOVT. OF INDIA, ANDHERI (EAST), MUMBAI

Kk tekke keke kee

AGENDA NOTE FOR CONSIDERATION OF APPROVAL COMMITTEE

a. Proposal :

Application received from M/s. SRV Global Freight Pvt. Ltd. for addition of area admeasuring 4,370.05 Sq. ft. to the already existing SEZ Unit located at NSBP-FTWZ, JNPA, Uran, Navi Mumbai without revision in projections .

b. Specific Issue on which decision of AC is required: -

Approval of the addition of area admeasuring 4,370.05 Sq. ft. to the existing SEZ Unit located at NSBP-FTWZ, JNPA without revision in projections.

c. Relevant provisions of SEZ Act, 2005 & Rules, 2006/Instruction/ Notification :-

Rule 19(2) of the SEZ Rules, 2006 provides as under:

“Provided that the Approval Committee may also approve proposals for broad banding, diversification, enhancement of capacity of production, change in item of manufacture or services activity if it meets the requirement of Rule 18.”

d. Other Information: -

|Name ofthe Unit|M/s. SRVGlobalFreight Pvt. Ltd|M/s. SRVGlobalFreight Pvt. Ltd|
|---|---|---|
||Located atNSBP-FTWZ inINPASEZ, Uran, Navi Mumbai—400702||
||||10,000$4|
|LOANo.& Date|SEEPZ/NEWSEZ/JNPA-SEZ/SGF/100/2025-26/04871||
|Authorized Operations /Services||Service OrientedActivity|
|Validity ofLOA||Up to 07.05.2027|
|ProposedAdditionalArea|RODEEIWZ,Uran,Navi|NaviMumbai—400702admeasuring 4,370.05 Sq.|
|Whethercopy ofAgreement/LOI<br>:<br>submitted||Yes|
||The Office of the|Specified<br>Officer, JNPA SEZ has verified the|
|.<br>;<br>;<br>Verification reportfrom the Specified<br>officer|proposed<br>area and<br>|igemarcated within <br>Photographs of the|confirmed<br>that the same<br>has been properly<br> the warehouse premises by use of plyboards.<br> site verification have also been submitted by the|
||AuthorizedOfficer.||

|

A. Total Area after Addition

The details of existing and proposed areas are as under:

Existing Location & Area Proposed Additional Area

Total Area after Addition

—_

; | |

| 1

}

i

{ \ : | |

| ; |

'

==> picture [519 x 139] intentionally omitted <==

----- Start of picture text -----<br> Existing Location & Area Proposed Additional Area Total Area after Addition |<br>Warehouse no.03, Plot No. 406/FTWZ, ||Warehouse no.03, Plot No. 406/FTWZ, ||Warehouse no.03, Plot No. 406/FTWZ,<br>Sector-4, in M/s. NSBP, Co-developer || Sector-4, in M/s. NSBP, Co-developer |Sector-4, in M/s. NSBP, Co-developer at] -<br>at M/s. JNPA, Village Sawarkhar, at M/s. JNPA, Village Sawarkhar, M/s. JNPA, Village Sawarkhar, Taluka-<br>Taluka-Uran, District-Raigad, Navi Taluka-Uran, District-Raigad, Navi Uran, District-Raigad, Navi Mumbai- .<br>Mumbai-400707 Mumbai-400707 400707<br>Admeasuring Area —<br>Admeasuring Area — 10,000. Sq. ft Admeasuring Area 4370.05 Sq ft<br>14,370.05 (4,376.05 + 16,006)<br>----- End of picture text -----<br>

The applicant has further submitted that employment projections have been revised in accordance with the expanded operations.

|

| .... ..B. Employment Projections for Next Five Years: \

C. Ne Revision in Approved Projections

| The unit has submitted that there is no revision in the approved projections relating to exports, investment, Net Foreign Exchange (NFE) and employment.

_

.

Further, the unit has undertaken to comply with all applicable restrictions, guidelines and directives issued from time to time by the Directorate General of Foreign Trade (DGFT) and Ministry of Commerce & Industry and to ensure compliance with the provisions of the provisions of provisions of of the SEZ Act, 2005 and Rules framed thereunder. SEZ Act, 2005 and Rules framed thereunder. Act, 2005 and Rules framed thereunder. 2005 and Rules framed thereunder. Rules framed thereunder. framed thereunder. thereunder.

| with the provisions of the provisions of provisions of of the SEZ Act, 2005 and Rules framed thereunder. SEZ Act, 2005 and Rules framed thereunder. Act, 2005 and Rules framed thereunder. 2005 and Rules framed thereunder. Rules framed thereunder. framed thereunder. thereunder. : The unit has also informed that, based on its business requirements, they have revised space admeasuring approximately | 14,370.05 Sq. Ft. which has been allotted by the NSBP Co-Developer and copy of the allotment letter has been submitted. | The unit has stated that the allotted space is sufficient for commencement of operations. Further, in case of any future requirement of additional space, the unit shall approach the competent authority separately for necessary approval, as applicable.

e. Recommendation:

The proposal of the unit for addition of area admeasuring 4,370.05 Sq. ft. to the existing unit located at NSBPFTWZ, JNPA without revision in projections is placed before the Approval Committee for consideration.

HK KAKI IER ERIE REE RIKER ER EEE ER REE

;

|

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 27779 --apply.

Citation copied